|4Dec 21, 6:38 PM ET

KORNMAN KENNETH S 4

4 · INTERLEUKIN GENETICS INC · Filed Dec 21, 2012

Insider Transaction Report

Form 4
Period: 2012-12-21
KORNMAN KENNETH S
DirectorChief Scientific Officer/Pres.
Transactions
  • Award

    Stock Option (Right to Buy)

    2012-12-21+300,000300,000 total
    Exercise: $0.34Exp: 2022-12-21Common Stock (300,000 underlying)
Footnotes (2)
  • [F1]The exercise price of the option is the closing price of the issuer's common stock on the OTCQB on 12/21/2012, which was the grant date of the option.
  • [F2]The option vests as to 75,000, 100,000 and 125,000 shares on the first, second and third anniversaries of the grant date, respectively.

Documents

1 file
  • 4
    v330861_4.xmlPrimary

    OWNERSHIP DOCUMENT